PREDICINE

Company Snapshot

Founded: 2015
Headquarter: U.S.
Key Geographics: U.S., China
Corporate Address: 3555 Arden Road Hayward, California 94545 U.S. Tel: +1-650-300-2188 Web: www.predicine.com

Company Overview

Predicine Inc., founded in 2015, is developing and marketing liquid biopsy diagnostics, initially focusing on the Chinese market. The company’s Gene Radar platform analyzes both ctDNA and ctRNA in a single blood sample.

Predicine markets PredicineATLAS, PredicineCARE, PredicineRNA, PredicineHEME and Predicine cfWES. The company provides harmonized assays supported by unified quality management systems and workflow in its network of CLIA-certified and CAP-accredited facilities in the U.S. and China to support cross-border clinical studies.

PREDICINE In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Report for DNA Sequencing Industry. Global market for DNA sequencing technologies and their applications in research, applied and clinical segments.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Company's Business Segments

  • Biopharma Solutions : This segment provides genomic profiling and technologies help biopharmaceutical partners and researchers to accelerate new precision medicine developments.

Applications/End User Industries

  • Pharmaceutical
  • Healthcare
  • Academic Institutions